CannabisNewsBreaks – MediPharm Labs Corp. (TSX: LABS) Secures C$37.8M in Private Placement
MediPharm Labs (TSX: LABS), a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, has closed a private placement with an institutional investor for aggregate gross proceeds of C$37,822,500. According to the update, MediPharm Labs intends to use the proceeds for general corporate purposes, including building on the launch of its cannabis 2.0 offerings with new product formats and expanding its product and active pharmaceutical ingredient exports. In addition, the proceeds will strengthen the company’s balance sheet in successful navigation through the economic recession created by the COVID-19 pandemic. Roth Capital Partners acted as sole placement agent…






